Shareholder Alert: Ademi LLP investigates whether DICE Therapeutics, Inc. has obtained a Fair Price in its transaction with Eli Lilly and Company

MILWAUKEE, June 20, 2023 /PRNewswire/ — Ademi LLP is investigating DICE (NASDAQ: DICE) for possible breaches of fiduciary duty and other violations of law in its transaction with Eli Lilly and Company. Click here to learn how to join the action…